Clinical trial
Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients
NCT04804566 is registered in ClinicalTrials.gov with Amicus Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients
- Lead sponsor
- Amicus Therapeutics
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2023
- Completion date
- November 1, 2023
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.